Verinata Health has appointed Vance Vanier as president, Keith Jones as senior vice president of research and development, and Suchetta Bhatta as vice president of genetics.
Vanier joined Verinata from Navigenics, where he most recently served as president and CEO. He was also a partner in the life sciences practice of Mohr Davidow Ventures. He holds an MD from Johns Hopkins School of Medicine and an MBA and BS from Stanford University.
Jones joined Verinata from Affymetrix, where he served as vice president of assay and application product development for the genetic analysis business unit. Previously, he was a research fellow at Affymax Research Institute and also held various roles at Spectra Biomedical and ImmuLogic. He holds a PhD in pharmacology from Stanford University and BS degrees in biology and chemistry from the University of California, Irvine.
Bhatt previously worked at Genzyme Genetics, where she was most recently medical director and director of the prenatal diagnosis center. Before joining Genzyme, she was in pediatric practice. She holds a master of surgery in ophthalmology, a bachelor of medicine, and bachelor of surgery degree from the University of Bombay.
Max Coppes has been named president of the BC Cancer Agency in Vancouver. Coppes formerly was senior vice president of the Children's National Medical Centre, where he led the Center for Cancer and Blood Disorders. While serving as president at the agency, Coppes will continue to teach and practice medicine at the University of British Columbia and the BC Children's Hospital.